THINKER
Transplanting Hepatitis C Kidneys into Negative Kidney Recipients
Patient / Population Intervention / Exposure Comparison Outcome
In 20 HCV-negative recipients of hepatitis-C-viraemic donor kidneys, antiviral therapy achieved a sustained virologic response in every patient.
N
10
Design
Open-label single-centre pilot
Endpoint
Sustained virologic response at 12 weeks (SVR12)
Relevance
3
ResultSVR12 100% (20/20); median 6-month creatinine 1.1 mg/dL.
Goldberg DS, et al. N Engl J Med. 2017;376(24):2394-2395. 10.1056/NEJMc1705221
Discussion & critique
Unlocked a previously discarded donor pool; now standard practice in many US centres.